Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis

Area of Science:

• Gastroenterology
• Natural Product Research
• Clinical Trial Analysis

Background:

• Ulcerative colitis (UC) management faces challenges, with a significant portion of patients unresponsive to standard treatments.
• Natural compounds, like curcumin, are being explored as potential therapeutic agents for UC.
• Existing research on curcumin for UC has limitations, including varied administration routes and patient disease states.

Purpose of the Study:

• To systematically review and meta-analyze randomized clinical trials (RCTs) evaluating oral curcumin for mild-to-moderate active ulcerative colitis.
• To address biases present in previous meta-analyses by standardizing administration routes and patient disease severity.
• To assess the efficacy of curcumin in inducing remission for UC patients.

Main Methods:

• Systematic review and meta-analysis of randomized clinical trials (RCTs).
• Inclusion criteria focused on orally administered curcumin in patients with mild-to-moderate active UC.
• Analysis aimed to minimize biases related to administration routes and disease stage.

Main Results:

• Curcumin demonstrates significant anti-inflammatory and antioxidant effects beneficial for UC remission.
• The meta-analysis suggests curcumin can aid in inducing remission for UC subjects.
• Standardization of curcumin dosage and administration routes remains an area for further research.

Conclusions:

• Curcumin possesses anti-inflammatory and antioxidant properties crucial for managing ulcerative colitis.
• This meta-analysis provides evidence for curcumin's efficacy in inducing remission in UC patients, with minimized study biases.
• Further research is needed to standardize curcumin's dose and administration for optimal UC treatment.